Kenvue Marks Independence By Extending Motrin And Tylenol Lines With Help From A Competitor

Kenvue also not standing apart from competitors concerning headwinds from foreign exchange rates, a slow start to the cough/cold season and looking ahead to FDA decision on oral phenylephrine, it reports with its third-quarter results.